Lee Danner & Bass Inc Pfizer Inc Transaction History

Lee Danner & Bass Inc

  • $1.42 Billion
  • Q3 2024

A detailed history of Lee Danner & Bass Inc transactions in Pfizer Inc stock. As of the latest transaction made, Lee Danner & Bass Inc holds 126,241 shares of PFE stock, worth $3.47 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
126,241
Previous 128,861 2.03%
Holding current value
$3.47 Million
Previous $3.61 Million 1.3%
% of portfolio
0.26%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$27.7 - $31.39 $72,574 - $82,241
-2,620 Reduced 2.03%
126,241 $3.65 Million
Q2 2024

Jul 30, 2024
SELL
$25.26 - $29.6 $196,623 - $230,406
-7,784 Reduced 5.7%
128,861 $3.61 Million
Q4 2023

Feb 01, 2024
SELL
$26.13 - $33.94 $528,348 - $686,266
-20,220 Reduced 12.89%
136,645 $3.93 Million
Q3 2023

Oct 27, 2023
SELL
$32.09 - $37.51 $15,692 - $18,342
-489 Reduced 0.31%
156,865 $5.2 Million
Q2 2023

Jul 31, 2023
SELL
$36.12 - $41.79 $137,617 - $159,219
-3,810 Reduced 2.36%
157,354 $5.77 Million
Q1 2023

May 02, 2023
SELL
$39.39 - $51.28 $604,557 - $787,045
-15,348 Reduced 8.7%
161,164 $6.58 Million
Q4 2022

Feb 01, 2023
SELL
$41.75 - $54.5 $430,776 - $562,331
-10,318 Reduced 5.52%
176,512 $9.04 Million
Q3 2022

Oct 31, 2022
SELL
$43.76 - $53.42 $102,398 - $125,002
-2,340 Reduced 1.24%
186,830 $8.18 Million
Q2 2022

Jul 25, 2022
SELL
$46.53 - $55.17 $231,486 - $274,470
-4,975 Reduced 2.56%
189,170 $9.92 Million
Q1 2022

Apr 27, 2022
BUY
$45.75 - $56.69 $81,160 - $100,568
1,774 Added 0.92%
194,145 $10.1 Million
Q4 2021

Jan 27, 2022
SELL
$41.32 - $61.25 $84,995 - $125,991
-2,057 Reduced 1.06%
192,371 $11.4 Million
Q3 2021

Nov 01, 2021
BUY
$39.25 - $50.42 $46,393 - $59,596
1,182 Added 0.61%
194,428 $8.36 Million
Q2 2021

Jul 27, 2021
BUY
$35.91 - $40.68 $223,396 - $253,070
6,221 Added 3.33%
193,246 $7.57 Million
Q1 2021

Apr 29, 2021
BUY
$33.49 - $37.77 $55,291 - $62,358
1,651 Added 0.89%
187,025 $6.78 Million
Q4 2020

Feb 09, 2021
BUY
$33.47 - $42.56 $750,330 - $954,110
22,418 Added 13.76%
185,374 $6.82 Million
Q3 2020

Nov 12, 2020
SELL
$31.75 - $37.25 $91,376 - $107,205
-2,878 Reduced 1.74%
162,956 $5.98 Million
Q2 2020

Aug 10, 2020
SELL
$30.12 - $36.54 $176,774 - $214,453
-5,869 Reduced 3.42%
165,834 $5.42 Million
Q1 2020

May 04, 2020
BUY
$27.03 - $38.62 $279,003 - $398,635
10,322 Added 6.4%
171,703 $5.6 Million
Q4 2019

Feb 13, 2020
BUY
$32.92 - $37.36 $121,771 - $138,194
3,699 Added 2.35%
161,381 $6.32 Million
Q3 2019

Oct 30, 2019
BUY
$32.49 - $42.13 $76,156 - $98,752
2,344 Added 1.51%
157,682 $5.67 Million
Q2 2019

Jul 30, 2019
SELL
$36.98 - $41.52 $297,541 - $334,069
-8,046 Reduced 4.92%
155,338 $6.73 Million
Q1 2019

May 06, 2019
SELL
$37.5 - $41.2 $90,862 - $99,827
-2,423 Reduced 1.46%
163,384 $6.94 Million
Q4 2018

Jan 29, 2019
SELL
$38.47 - $43.86 $12,579 - $14,342
-327 Reduced 0.2%
165,807 $7.24 Million
Q3 2018

Nov 06, 2018
SELL
$34.47 - $41.81 $148,841 - $180,535
-4,318 Reduced 2.53%
166,134 $7.32 Million
Q2 2018

Nov 02, 2018
BUY
$32.98 - $35.16 $64,179 - $68,421
1,946 Added 1.15%
170,452 $6.18 Million
Q2 2018

Aug 06, 2018
SELL
$32.98 - $35.16 $42,115 - $44,899
-1,277 Reduced 0.75%
168,506 $6.73 Million
Q1 2018

May 02, 2018
BUY
$31.91 - $37.02 $133,990 - $155,446
4,199 Added 2.54%
169,783 $6.03 Million
Q4 2017

Feb 02, 2018
SELL
$33.26 - $35.29 $212,464 - $225,432
-6,388 Reduced 3.71%
165,584 $6 Million
Q3 2017

Oct 27, 2017
BUY
$31.0 - $34.15 $5.33 Million - $5.87 Million
171,972
171,972 $6.14 Million

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lee Danner & Bass Inc Portfolio

Follow Lee Danner & Bass Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email